Open
亞家生物科技鎖定免疫細胞治療、幹細胞療法以及非基因改造T細胞療法等專業核心技術，並自建四大平台：幹細胞、免疫細胞量產擴增技術平台、PIC/S GMP量產技術平台與AI製程技術平台。
The technology of YJ Biotech began in 2014 when it was founded by Carlos Wu, who recruited a team of cell culture and pharmaceutical experts with over fifteen years of experience. The company is dedicated to researching cost effective PIC/S GMP-grade cell processes. After six years of development, the company was established in March 2020. It has built a decentralized intelligent cell factory in Linkou, Taiwan, showcasing the concept of "clinic in front, cell factory behind"
The technology of YJ Biotech began in 2014 when it was founded by Carlos Wu, who recruited a team of cell culture and pharmaceutical experts with over fifteen years of experience. The company is dedicated to researching cost effective PIC/S GMP-grade cell processes. After six years of development, the company was established in March 2020. It has built a decentralized intelligent cell factory in Linkou, Taiwan, showcasing the concept of "clinic in front, cell factory behind"